LM-2616

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameLM-2616

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionBeta-1 adrenergic receptor antagonistsBeta-2 adrenergic receptor agonists

TargetsBeta-2 adrenergic receptorBeta-1 adrenergic receptor

Therapy Area/IndicationsHeart FailureArrhythmias, Cardiac

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIndia

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesN/A

China Registration ClassN/A

Active CompaniesN/A

Inactive Companies +[1] N/A

Active IndicationsN/A

Inactive IndicationsHeart FailureArrhythmias, Cardiac

ATC CodeN/A